Saaristo A - Search Results

1

Perspectives on lymphangiogenesis and angiogenesis in cancer.

Holopainen T, Bry M, Alitalo K, Saaristo A. Holopainen T, et al. Among authors: saaristo a. J Surg Oncol. 2011 May 1;103(6):484-8. doi: 10.1002/jso.21808. J Surg Oncol. 2011. PMID: 21480240 Review.

2

Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

Saaristo A, Karpanen T, Alitalo K. Saaristo A, et al. Oncogene. 2000 Dec 11;19(53):6122-9. doi: 10.1038/sj.onc.1203969. Oncogene. 2000. PMID: 11156525 Review.

3

Insights into the molecular pathogenesis and targeted treatment of lymphedema.

Saaristo A, Karkkainen MJ, Alitalo K. Saaristo A, et al. Ann N Y Acad Sci. 2002 Dec;979:94-110. doi: 10.1111/j.1749-6632.2002.tb04871.x. Ann N Y Acad Sci. 2002. PMID: 12543720 Review.

4

Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema.

Honkonen KM, Visuri MT, Tervala TV, Halonen PJ, Koivisto M, Lähteenvuo MT, Alitalo KK, Ylä-Herttuala S, Saaristo AM. Honkonen KM, et al. Among authors: saaristo am. Ann Surg. 2013 May;257(5):961-7. doi: 10.1097/SLA.0b013e31826ed043. Ann Surg. 2013. PMID: 23013803

5

Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.

Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ, Kerjaschki D, Bueler H, Ylä-Herttuala S, Alitalo K. Saaristo A, et al. FASEB J. 2002 Jul;16(9):1041-9. doi: 10.1096/fj.01-1042com. FASEB J. 2002. PMID: 12087065

6

Lymphangiogenic gene therapy with minimal blood vascular side effects.

Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Ylä-Herttuala S, Alitalo K. Saaristo A, et al. J Exp Med. 2002 Sep 16;196(6):719-30. doi: 10.1084/jem.20020587. J Exp Med. 2002. PMID: 12235206 Free PMC article.

7

Lymphangiogenic growth factors, receptors and therapies.

Lohela M, Saaristo A, Veikkola T, Alitalo K. Lohela M, et al. Among authors: saaristo a. Thromb Haemost. 2003 Aug;90(2):167-84. doi: 10.1160/TH03-04-0200. Thromb Haemost. 2003. PMID: 12888864 Review.

8

Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds.

Saaristo A, Tammela T, Timonen J, Yla-Herttuala S, Tukiainen E, Asko-Seljavaara S, Alitalo K. Saaristo A, et al. FASEB J. 2004 Nov;18(14):1707-9. doi: 10.1096/fj.04-1592fje. Epub 2004 Sep 10. FASEB J. 2004. PMID: 15361472

9

Vascular endothelial growth factor-C accelerates diabetic wound healing.

Saaristo A, Tammela T, Farkkilā A, Kärkkäinen M, Suominen E, Yla-Herttuala S, Alitalo K. Saaristo A, et al. Am J Pathol. 2006 Sep;169(3):1080-7. doi: 10.2353/ajpath.2006.051251. Am J Pathol. 2006. PMID: 16936280 Free PMC article.

10

Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation.

Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, Abo-Ramadan U, Ylä-Herttuala S, Petrova TV, Alitalo K. Tammela T, et al. Among authors: saaristo a. Nat Med. 2007 Dec;13(12):1458-66. doi: 10.1038/nm1689. Epub 2007 Dec 2. Nat Med. 2007. PMID: 18059280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters